title: Long-term visual outcome of childhood blepharokeratoconjunctivitis.
abstract: OBJECTIVE
  To assess the visual outcome of childhood blepharokeratoconjunctivitis.
  
  
  METHODS
  Retrospective noncomparative case series.
  
  
  METHODS
  We reviewed visual acuity and corneal examination results for 23 patients (mean age 19 +/- 4 years, range, 11 to 26 years) who had healed more than three years previously (up to 15 years).
  
  
  RESULTS
  The disease involved 29 eyes and was unilateral in 17 children. Corneal sequelae (neovascularization or scars) involved 18 eyes (62%) of 15 children (65%). Mean best-corrected visual acuity was 20/25 (range, 20/100 to 20/20). Best-corrected visual acuity was no more than 20/30 in seven eyes (24%) of seven children (30%). Fifteen eyes (52%) of 13 children (45%) had astigmatisms of at least 0.75 diopters attributable to corneal scars.
  
  
  CONCLUSIONS
  Corneal and visual sequelae are frequent in childhood blepharokeratoconjunctivitis. Early diagnosis and specific treatment are mandatory.
authors.affiliation: Department of Ophthalmology, Bichat Hospital and Fondation A. de Rothschild, Paris, France. serge.doan@noos.fr
authors.forename: Serge
authors.initials: S
authors.lastname: Doan
authors.forename: Eric E
authors.initials: EE
authors.lastname: Gabison
authors.forename: Sylvia
authors.initials: S
authors.lastname: Nghiem-Buffet
authors.forename: Olivia
authors.initials: O
authors.lastname: Abitbol
authors.forename: Damien
authors.initials: D
authors.lastname: Gatinel
authors.forename: Thanh
authors.initials: T
authors.lastname: Hoang-Xuan
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy / Q000503:physiopathology*; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000503:physiopathology*; D018942:Macrolides / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D013752:Tetracycline / Q000627:therapeutic use; D014792:Visual Acuity / Q000502:physiology*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D005672:Fusidic Acid; D013752:Tetracycline